Live Breaking News & Updates on Health Status Benefits Of Mavacamten

New analysis of EXPLORER-HCM trial assessing impact of mavacamten on patient’s health status to be presented as late-breaking oral presentation Interim results of EXPLORER long-term extension study of mavacamten safety and efficacy data in patients with obstructive hypertrophic cardiomyopathy also to be presented Bristol Myers Squibb today announced that data from multiple studies across the company’s clinical …
New analysis of EXPLORER-HCM trial assessing impact of mavacamten on patient’s health status to be presented as late-breaking oral presentation
Interim results of EXPLORER long-term extension study of mavacamten safety and efficacy data in patients with obstructive hypertrophic cardiomyopathy (oHCM) ....

United States , Jay Edelberg , Johna Spertus , Bristol Myers Squibb , Susan Francis , Snehas Jain , Florian Rader , American College Of Cardiology , Clinical Researchi Session , Exchange Commission , Cardiomyopathy Development At Bristol Myers Squibb , Clinical Research , Health Status Benefits Of Mavacamten , Myers Squibb , American College , Annual Scientific Session , Kansas City Cardiomyopathy , Featured Clinical Researchi Session , Hot Topics Channel , Heart Failure , Cardiomyopathy Development , Bristol Myers , Status Benefits , Symptomatic Obstructive Cardiomyopathy , Results From , Clinical Trial ,